4th US FDA-drug information association pharmacogenomics workshop, held 10-12 December, 2007

Pharmacogenomics

Volumn 10, Issue 1, 2009, Pages 111-115

  Frueh, Felix W ^a,b   Salerno, Ronald A ^c   Lesko, Lawrence J ^b   Hockett, Richard D ^d  

^a Medco Health Solutions Inc   (United States)

^b CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^c Biologics Consulting Group Inc   (United States)

^d ELI LILLY AND COMPANY   (United States)

Author keywords

Biomarkers; Drug development; Regulatory decision making

Indexed keywords

BIOLOGICAL MARKER; DRUG; WARFARIN; PHARMACOLOGICAL BIOMARKER;

CONFERENCE PAPER; COST EFFECTIVENESS ANALYSIS; DRUG INDUSTRY; DRUG INFORMATION; DRUG UTILIZATION; FOOD AND DRUG ADMINISTRATION; GENETIC VARIABILITY; GENOTOXICITY; GENOTYPE; MEDICAL DECISION MAKING; MEDICAL EDUCATION; PHARMACOGENOMICS; PHENOTYPE; POSTMARKETING SURVEILLANCE; PRACTICE GUIDELINE; PRODUCT DEVELOPMENT; REIMBURSEMENT; RISK BENEFIT ANALYSIS; ANIMAL; DRUG DESIGN; HUMAN; PHARMACOGENETICS; UNITED STATES;

ANIMALS; BIOMARKERS, PHARMACOLOGICAL; DRUG DESIGN; HUMANS; PHARMACOGENETICS; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 62649103392     PISSN: 14622416     EISSN: 17448042     Source Type: Journal    
DOI: 10.2217/14622416.10.1.111     Document Type: Conference Paper

References (0)